Company
Engimmune Therapeutics
- Biotech
- Founded:
- 2021
- Location:
- Allschwil, Switzerland
Description
Engimmune Therapeutics engineers off-the-shelf, soluble T-cell receptor (TCR) therapeutic proteins using AI-guided protein engineering, multi-specific design, and stability optimization to target solid-tumor oncology and immune-mediated disease indications in preclinical development.
Related
CimCureCimCure develops conjugate cancer vaccines that induce antibody responses against tumour blood-vessel targets, applying its proprietary…
NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
21st.BIO21st.BIO A/S provides precision fermentation technology for proteins and peptides, using microbial strains, fermentation processes, and…
3B Pharmaceuticals3B Pharmaceuticals develops targeted radiopharmaceuticals under a targeted radiotherapy program that builds peptide‑based theragnostic and…
3H Biomedical3H Biomedical supplies researchers with a broad catalog of primary human and animal cells, purified nucleic acids, cell culture media, and…
AbbelightAbbelight provides integrated microscopy and nanoscopy instruments, reagents, and analysis software for quantitative bioimaging workflows,…
Ability PharmaAbility Pharma develops oral targeted anticancer compounds that induce cytotoxic autophagy in cancer cells and advances clinical-stage…
- ACD PharmaACD Pharma develops bacteriophage-based biocontrol products and technologies for preventing and treating bacterial infections, with…
AciesBioAciesBio provides microbial biotech services for strain engineering, scale-up process design, fermentation-broth processing, contract…